Sanofi Fined $53M In France Over Generic Plavix Smears
France's antitrust regulator has fined Sanofi SA €40.6 million ($52.7 million) after ruling the drugmaker had engaged in a campaign to discourage doctors and pharmacists from prescribing or substituting generic versions...To view the full article, register now.
Already a subscriber? Click here to view full article